作者:Mei Zhong、Yanjuan Liu、Junxi Liu、Duolong Di、Mengrou Xu、Yaya Yang、Wenguang Li、Yali Chen、Jinxia Liu
DOI:10.3390/molecules190812099
日期:——
In order to improve the anticancer activity of isocorydine (ICD), ten isocorydine derivatives were prepared through chemical structure modifications, and their in vitro and in vivo activities were experimentally investigated. 8-Amino-isocorydine (8) and 6a,7-dihydrogen-isocorydione (10) could inhibit the growth of human lung (A549), gastric (SGC7901) and liver (HepG2) cancer cell lines in vitro. Isocorydione
为提高异紫堇碱(ICD)的抗癌活性,通过化学结构修饰制备了10种异紫堇衍生物,并对其体内外活性进行了实验研究。8-Amino-isocorydine (8) 和 6a,7-dihydrogen-isocorydione (10) 可在体外抑制人肺 (A549)、胃 (SGC7901) 和肝 (HepG2) 癌细胞系的生长。Isocorydione (2) 可以抑制携带 S180 小鼠肉瘤小鼠的肿瘤生长,8-acetamino-isocorydine (11) 是 8-amino-isocorydine (8) 的前药,在室温下在水溶液中不稳定, 对鼠肝癌 H22 诱导的肿瘤有很好的抑制作用。结果表明,C-8 位异花椰菜碱的结构修饰可以显着提高该生物碱的生物活性,